Brain Modulation News Today

NEWS RELEASE Contacts: Erika Winkels Public Relations +1-763-526-8478 ...

FINAL Q4 FY24 Earnings call commentary Ryan Weispfenning Good...

Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business...

/CNW/ -- Medtronic plc (NYSE:MDT) today announced financial results for its third quarter (Q3) of fiscal year 2024 (FY24), which ended January 26, 2024. Key...

Doctors have completed the first U.S. implants of the Medtronic Percept RC neurostimulator for deep brain stimulation (DBS).

Medtronic, a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system.

Rechargeable neurostimulator joins the Medtronic Percept™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming. DUBLIN, Jan. 8, 2024...

Medtronic won FDA approval of its Percept RC deep brain stimulation system, the latest member of its Percept line of DBS devices.

/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its...

Medtronic announced that it received CE mark approval for its Percept RC neurostimulation device.